Article Details
Retrieved on: 2025-04-14 22:19:21
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the rapid growth of the viral vector and plasmid DNA manufacturing market, fueled by increased demand from gene therapies and DNA vaccines. It highlights that venture capital funding supports advancements in biotechnology, vital for breakthroughs in gene therapy and vaccine development, including innovations like ZyCoV-D.
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here